Massachusetts Cannabis Repeal Vote: What's at Stake in 2026

Executive Summary

Massachusetts voters face a November 2026 ballot question that would repeal the state's adult-use cannabis legalization, reversing a decade of legal recreational sales and potentially shuttering a $1.8 billion annual market. The repeal initiative, organized by a coalition of parent groups and municipal leaders, gathered sufficient signatures to place Question 4 on the statewide ballot after citing concerns about youth access, impaired driving incidents, and neighborhood impacts from retail dispensaries. If approved, the measure would eliminate Chapter 334 of the Acts of 2016—the ballot law that legalized possession and retail sales for adults 21 and older—while preserving the state's medical marijuana program established in 2012. The September 19, 2026 rally at Boston Common drew an estimated 8,000 advocates in what organizers called the largest cannabis policy demonstration in Massachusetts history, occurring exactly six weeks before Election Day.

The repeal effort represents the first serious attempt by any state to reverse adult-use legalization through the ballot box. Massachusetts legalized recreational cannabis in November 2016 with 53.7% voter approval, and retail sales commenced in November 2018. The state now hosts 403 active retail licenses generating approximately $150 million in annual tax revenue. Polling conducted in August 2026 showed the repeal question trailing 58% to 35%, with 7% undecided, though both campaigns acknowledge the outcome remains uncertain given historical volatility in cannabis ballot measures during the final weeks before voting.

Why This Matters

The Massachusetts repeal vote carries implications far beyond state borders, potentially establishing a precedent for cannabis policy reversal nationwide and affecting $35 billion in U.S. cannabis market capitalization. Twenty-four states have legalized adult-use cannabis since Colorado and Washington became the first in 2012, but no state has subsequently repealed legalization through voter referendum. A successful repeal in Massachusetts would provide a roadmap for prohibition advocates in other states and could trigger capital flight from multi-state operators with significant Massachusetts exposure.

The state's cannabis industry directly employs 14,200 workers across cultivation, manufacturing, testing, and retail operations, according to Massachusetts Cannabis Control Commission data from June 2026. An additional 8,700 jobs exist in ancillary sectors including security, legal services, real estate, and equipment supply. The repeal language includes no transition provisions for existing businesses, creating uncertainty about whether operators would face immediate closure or a wind-down period.

Medical cannabis patients represent another critical stakeholder group. Massachusetts serves approximately 78,000 registered medical patients through 183 licensed medical dispensaries, many of which operate as dual-license facilities also serving adult-use customers. The repeal initiative explicitly preserves medical access under Chapter 369 of the Acts of 2012, but industry analysts warn that eliminating the larger adult-use market could make medical-only operations financially unviable, particularly for smaller operators.

Municipal governments face fiscal exposure as well. The state's 117 municipalities hosting cannabis retailers collected $47.3 million in local impact fees and community host agreements during fiscal year 2025, funds often dedicated to police, schools, and infrastructure. Boston alone collected $8.2 million from its 38 licensed retailers. The repeal would eliminate this revenue stream while potentially increasing enforcement costs if illicit markets expand to fill demand.

Background and History: From Decriminalization to Repeal

Massachusetts cannabis policy evolved through four distinct voter-approved ballot measures over 18 years before the current repeal effort emerged. Understanding this timeline provides essential context for the 2026 vote.

2008: Decriminalization Initiative

Massachusetts voters approved Question 2 in November 2008 with 65% support, making possession of one ounce or less of cannabis a civil violation punishable by a $100 fine rather than criminal charges. The measure, codified as Chapter 387 of the Acts of 2008, eliminated arrest and criminal records for small-scale possession while maintaining criminal penalties for distribution and cultivation. Supporters argued the change would reduce racial disparities in enforcement and save law enforcement resources. The initiative passed despite opposition from then-Governor Deval Patrick and most district attorneys.

2012: Medical Marijuana Legalization

Question 3 on the November 2012 ballot established a regulated medical cannabis program, passing with 63% approval. The Massachusetts Medical Marijuana Act, codified as Chapter 369 of the Acts of 2012, authorized physicians to recommend cannabis for patients with debilitating conditions including cancer, glaucoma, HIV/AIDS, hepatitis C, Crohn's disease, Parkinson's disease, and multiple sclerosis. The law created a registration system administered by the Department of Public Health and authorized up to 35 nonprofit dispensaries statewide.

Implementation proceeded slowly. The first medical dispensaries opened in June 2015, nearly three years after voter approval, following extensive regulatory development and local approval processes. By November 2016, only 20 medical dispensaries operated statewide, serving approximately 24,000 registered patients.

2016: Adult-Use Legalization

The Campaign to Regulate Marijuana Like Alcohol placed Question 4 on the November 2016 ballot, proposing full legalization for adults 21 and older. The initiative passed with 53.7% support—a narrower margin than the earlier decriminalization and medical measures. The law, codified as Chapter 334 of the Acts of 2016, authorized adults to possess up to one ounce in public and ten ounces at home, cultivate up to six plants per person (twelve per household), and established a licensing framework for commercial cultivation, manufacturing, testing, and retail sales.

The measure created the Cannabis Control Commission as an independent regulatory agency separate from the Department of Public Health's medical program oversight. It imposed a 10.75% state excise tax on retail sales (later increased to 20% when combined with the standard 6.25% sales tax and optional local taxes up to 3%). Municipalities received authority to ban retail operations locally or negotiate community host agreements requiring impact fees.

Then-Governor Charlie Baker opposed the initiative and subsequently signed Chapter 55 of the Acts of 2017, legislative amendments that delayed retail sales from January 2018 to July 2018, increased the Cannabis Control Commission from three to five members, and strengthened municipal control over local licensing. The commission delayed implementation further, with the first adult-use retail sales occurring on November 20, 2018 at two dispensaries in Northampton and Leicester.

2023-2024: Repeal Movement Emerges

The Committee for Safe Communities Massachusetts formed in March 2023, led by former State Representative Colleen Garry of Dracut and Dr. Sharon Levy, director of the Adolescent Substance Use and Addiction Program at Boston Children's Hospital. The organization initially focused on municipal ballot questions to ban local retail sales, succeeding in 14 communities during the November 2023 elections.

In January 2024, the committee announced plans for a statewide repeal initiative. Organizers cited Massachusetts Department of Public Health data showing emergency department visits for cannabis-related diagnoses increased 83% between 2016 and 2023, from 4,712 to 8,623 annually. They also referenced Massachusetts State Police reports indicating cannabis-involved motor vehicle fatalities rose from 32 in 2016 to 58 in 2023, though causation remained disputed given the lack of reliable roadside THC testing.

The campaign submitted 110,273 signatures to the Secretary of State in November 2024, exceeding the 74,574 required for ballot access. After certification, the measure qualified as Question 4 on the November 3, 2026 ballot.

2025-2026: Campaign Intensifies

The Coalition to Protect Massachusetts Cannabis Access formed in February 2025 as the opposition campaign, funded primarily by multi-state operators including Curaleaf, Trulieve, and Verano Holdings. The coalition raised $18.7 million through June 2026, compared to $4.2 million raised by repeal advocates, according to Office of Campaign and Political Finance reports.

Both campaigns focused on suburban swing voters in communities like Framingham, Quincy, and Braintree—areas that narrowly supported legalization in 2016 but showed ambivalence in subsequent polling. The repeal campaign emphasized youth protection and public safety, while legalization defenders highlighted tax revenue, job creation, and the risk of re-criminalizing consumers.

The September 19, 2026 rally at Boston Common represented the opposition campaign's largest mobilization, drawing an estimated 8,000 participants according to Boston Police Department crowd estimates. Speakers included cannabis business owners, medical patients, criminal justice reform advocates, and several state legislators who opposed repeal.

Key Players and Stakeholders

Committee for Safe Communities Massachusetts

The repeal campaign operates as a coalition of parent organizations, municipal officials, and healthcare professionals concerned about youth access and public health impacts. Colleen Garry, the former state representative who chairs the committee, represented Dracut from 1995 to 2011 and previously worked as a substance abuse counselor. Dr. Sharon Levy serves as medical director, bringing credentials from Boston Children's Hospital and Harvard Medical School. The campaign received financial backing from Smart Approaches to Marijuana, a national organization founded by former U.S. Representative Patrick Kennedy, which contributed $1.8 million through June 2026.

The committee's messaging emphasizes three core arguments: increased youth cannabis use despite age restrictions, rising impaired driving incidents, and quality-of-life complaints in neighborhoods hosting dispensaries. Campaign materials cite Massachusetts Youth Health Survey data showing past-30-day cannabis use among high school students increased from 24.3% in 2017 to 27.8% in 2023, though this remains below the 29.7% rate recorded in 2013 before legalization.

Coalition to Protect Massachusetts Cannabis Access

The opposition campaign unites cannabis industry operators, social equity advocates, and criminal justice reform organizations under a single umbrella defending legalization. Executive Director James Borghesani previously served as spokesman for the 2016 legalization campaign and brings deep knowledge of Massachusetts voter attitudes. The coalition's $18.7 million war chest comes primarily from licensed operators with significant Massachusetts market share, including Curaleaf ($4.3 million), Trulieve ($3.8 million), and Verano ($2.9 million).

The campaign strategy focuses on economic arguments—tax revenue, jobs, and regulated supply chains—while emphasizing that repeal would re-criminalize possession for millions of adults who consume cannabis legally. Television advertising launched in August 2026 features small business owners, military veterans using medical cannabis, and former law enforcement officials warning about illicit market resurgence if legal sales end.

Cannabis Control Commission

The five-member regulatory body maintains official neutrality on the ballot question while preparing contingency plans for both outcomes. Chair Ava Callender Concepcion, appointed by Governor Maura Healey in 2024, leads a commission that oversees 1,247 active licenses across all cannabis business categories as of June 2026. The commission published a 47-page report in May 2026 analyzing repeal scenarios, concluding that immediate prohibition without transition provisions would likely trigger legal challenges from license holders and create enforcement chaos.

The commission's analysis estimated that abrupt closure of 403 retail locations would leave approximately 1.2 million regular consumers—based on survey data suggesting 18% of Massachusetts adults use cannabis monthly—without legal access, potentially driving demand to illicit sources or neighboring states including Maine, Vermont, and Rhode Island, all of which maintain legal adult-use markets.

Multi-State Operators

Publicly traded cannabis companies with significant Massachusetts exposure face material financial risk from repeal. Curaleaf Holdings operates 52 Massachusetts licenses including 31 retail locations, representing approximately 22% of the company's total U.S. revenue according to 2025 financial disclosures. Trulieve Cannabis Corp. holds 18 Massachusetts licenses following its 2024 acquisition of Heirloom Collective. Verano Holdings operates 14 licenses across cultivation, manufacturing, and retail.

Equity analysts estimate that a successful repeal could reduce aggregate market capitalization of U.S. multi-state operators by 8-12%, based on Massachusetts representing roughly 5% of total U.S. legal cannabis sales but carrying outsized symbolic importance as a potential reversal precedent. Several operators disclosed in August 2026 SEC filings that they maintain insurance policies covering regulatory change, though coverage limits and exclusions remain confidential.

Social Equity Stakeholders

Massachusetts established one of the nation's most comprehensive cannabis social equity programs, creating pathways for communities disproportionately harmed by prohibition to participate in the legal industry. The Cannabis Control Commission designated economic empowerment applicants and social equity program participants as priority license categories, offering technical assistance, reduced fees, and expedited review. As of June 2026, 127 social equity licensees operated in Massachusetts, representing 10.2% of all active licenses.

Repeal would disproportionately impact these operators, many of whom carry significant debt from startup costs and lack the diversified geographic footprint of multi-state operators. The Massachusetts Recreational Consumer Council, representing social equity businesses, opposes repeal and argues that prohibition's return would recreate the same enforcement disparities the equity program aimed to remedy.

Legal and Regulatory Framework

The repeal initiative would eliminate Chapter 334 of the Acts of 2016 in its entirety while preserving Chapter 369 of the Acts of 2012, creating a legal framework that reverts to medical-only access. The ballot question language, certified by Attorney General Andrea Campbell in December 2024, contains 187 words asking voters whether to repeal "the law regulating and taxing marijuana" while maintaining "the existing law allowing marijuana for medical use."

If approved, the repeal would take effect 30 days after the election under Article 48 of the Massachusetts Constitution, which governs initiative petitions. This would establish a December 3, 2026 implementation date, absent legislative intervention. The measure contains no transition provisions, creating legal ambiguity about whether existing licenses remain valid during any wind-down period or terminate immediately.

Constitutional scholars note that license holders could challenge repeal under the Contracts Clause of the U.S. Constitution (Article I, Section 10) and the Takings Clause of the Fifth Amendment, arguing that state-issued licenses constitute property interests protected from arbitrary revocation. However, Massachusetts courts have historically granted broad deference to voter-approved initiatives, and cannabis businesses face the additional hurdle that federal law still classifies cannabis as a Schedule I controlled substance under 21 U.S.C. § 812, potentially limiting constitutional protections.

The repeal would not affect criminal records or pending cases, as Massachusetts law provides no mechanism for automatic expungement of convictions predating legalization. Approximately 340,000 Massachusetts residents have criminal records for cannabis offenses occurring before 2008 decriminalization, according to Commonwealth Expungement Project estimates. Repeal would not alter their status, though it could complicate ongoing expungement petitions by eliminating the legal framework that justified record-clearing.

Tax implications remain complex. The repeal would eliminate the state's cannabis excise tax codified in M.G.L. c. 64N, which generated $149.7 million in fiscal year 2025. These funds support the Cannabis Control Commission's operating budget ($28.4 million in FY2025), municipal technical assistance grants ($12.1 million), public health programs ($31.2 million), and general revenue ($78 million). The state would need to identify alternative funding sources or reduce services, though the ballot question contains no appropriation language addressing this gap.

State-by-State Context: Massachusetts in National Perspective

Massachusetts represents the 24th state to legalize adult-use cannabis but would become the first to reverse legalization through voter referendum if Question 4 passes. Examining parallel developments in other states illuminates the unique aspects of the Massachusetts repeal effort.

Maine

Maine voters approved adult-use legalization in November 2016, the same election as Massachusetts, with 50.26% support—the narrowest margin of any successful cannabis legalization ballot measure. Retail sales commenced in October 2020 after extensive regulatory delays. Maine now hosts 387 active retail licenses serving a population of 1.4 million, compared to Massachusetts's 403 licenses serving 7.0 million residents. No organized repeal effort has emerged in Maine, though several municipalities banned local retail sales through local option votes.

Vermont

Vermont legalized possession and home cultivation through legislative action in 2018, becoming the first state to legalize without a voter referendum. The legislature authorized retail sales in 2020, with the first stores opening in October 2022. Vermont's legislative model provides greater flexibility for policy adjustment compared to voter-approved initiatives, which typically require subsequent voter approval to amend. No repeal legislation has been introduced in Vermont's General Assembly.

Rhode Island

Rhode Island legalized adult-use cannabis through legislative action in May 2022, with retail sales beginning in December 2022. The state now operates 33 licensed retailers. Rhode Island's proximity to Massachusetts creates competitive dynamics, as consumers can cross state lines for legal purchases. If Massachusetts repeals legalization, Rhode Island retailers could see increased demand from Massachusetts residents, though interstate transport remains federally illegal under 21 U.S.C. § 841.

California

California legalized adult-use cannabis through Proposition 64 in November 2016 with 57% approval. The state's $5.3 billion annual market dwarfs Massachusetts, but California has faced persistent challenges with illicit market competition and local bans covering 62% of municipalities. No statewide repeal effort has emerged, though several counties attempted local prohibition measures that failed at the ballot box. California's experience suggests that even in large, established markets, legalization remains politically contested.

Colorado

Colorado became the first state to implement legal adult-use sales in January 2014 following voter approval of Amendment 64 in November 2012. After 12 years of legal sales generating $15.5 billion in total revenue and $2.4 billion in tax collections, Colorado has seen no serious repeal efforts. Public opinion polling consistently shows 65-70% support for maintaining legalization, suggesting that long-term implementation builds durable political support. However, Colorado's experience may not translate to Massachusetts given different demographic and political contexts.

Market and Business Implications

Massachusetts cannabis retail sales totaled $1.83 billion in calendar year 2025, generating $149.7 million in state excise tax revenue and supporting 14,200 direct jobs across the supply chain. Repeal would eliminate this economic activity, though the magnitude and distribution of impacts depend on implementation details not specified in the ballot language.

The state's cannabis market operates across several distinct segments. Cultivation facilities hold 187 active licenses and produced 142,300 pounds of flower and 89,700 pounds of trim in 2025, according to Cannabis Control Commission seed-to-sale tracking data. Manufacturing facilities hold 312 licenses and produced 8.7 million units of edibles, concentrates, and infused products. Testing laboratories hold 23 licenses and analyzed 487,000 product batches for potency and contaminants. Retail dispensaries hold 403 licenses and completed 47.2 million individual transactions.

Wholesale pricing data illustrates market maturity. Average wholesale flower prices declined from $3,200 per pound in January 2019 to $1,450 per pound in June 2026, reflecting increased supply and competition. Concentrate wholesale prices fell from $18 per gram to $8 per gram over the same period. These price declines compressed operator margins but benefited consumers through lower retail prices, with average transaction values falling from $87 in 2019 to $62 in 2025.

Real estate implications extend beyond licensed operators. Massachusetts cannabis businesses lease approximately 4.2 million square feet of industrial and retail space, according to commercial real estate data compiled by cannabis industry analysts. Cultivation facilities typically occupy 15,000-50,000 square foot warehouses in industrial zones, while retail dispensaries average 2,500-4,000 square feet in commercial districts. Landlords collected an estimated $147 million in annual rent from cannabis tenants in 2025, and repeal could trigger lease defaults and vacancy increases in markets with concentrated cannabis activity.

Capital markets face uncertainty as well. Massachusetts cannabis businesses have attracted approximately $890 million in private investment since 2018, including debt and equity financing from regional banks, private equity funds, and individual investors. Most financing agreements contain material adverse change clauses that could allow lenders to accelerate repayment if legalization ends. The resulting financial distress could ripple through the broader cannabis industry by reducing investor confidence in state-legal markets generally.

Ancillary businesses face indirect exposure. Security companies, legal practices, accounting firms, equipment suppliers, and software vendors serving Massachusetts cannabis operators generated an estimated $340 million in annual revenue in 2025. While some could pivot to medical-only clients or out-of-state markets, the sudden contraction would likely force layoffs and business closures.

What Experts Say

Public health researchers, economists, and legal scholars have analyzed the repeal question from multiple disciplinary perspectives, reaching divergent conclusions about costs and benefits. Dr. Kevin Sabet, president of Smart Approaches to Marijuana and a supporter of repeal, said in August 2026 testimony before the Massachusetts Legislature's Joint Committee on Public Health that legalization failed to achieve promised benefits. According to Sabet, tax revenue has not met projections, youth use increased rather than decreased, and impaired driving incidents rose substantially. He characterized legalization as a "failed experiment" that Massachusetts should reverse before other states follow the same path.

Dr. Staci Gruber, director of the Marijuana Investigations for Neuroscientific Discovery program at McLean Hospital and Harvard Medical School, offered a more nuanced assessment in a September 2026 interview with the Boston Globe. According to Gruber, research shows that adult cannabis use does not cause the same developmental harms as adolescent use, and regulated markets provide quality control absent from illicit sources. She said the focus should be preventing youth access through enforcement rather than eliminating adult access through prohibition.

Economic analysis from the Beacon Hill Institute at Suffolk University, published in July 2026, estimated that repeal would eliminate 14,200 direct jobs and 8,700 indirect jobs, reduce state tax revenue by $150 million annually, and decrease economic output by $2.1 billion. The analysis, commissioned by the Coalition to Protect Massachusetts Cannabis Access, acknowledged potential offsetting benefits from reduced substance abuse treatment costs and impaired driving incidents but concluded the net economic impact would be substantially negative.

A competing analysis from the Pioneer Institute, a conservative policy research organization, reached different conclusions. According to the June 2026 report, the state's cannabis tax revenue is largely offset by increased costs for public health programs, law enforcement training, and regulatory administration. The report estimated net fiscal impact at just $47 million annually—far below the $150 million gross tax revenue—and argued this modest benefit does not justify the public health costs.

Legal scholars debate whether repeal would survive constitutional challenge. Professor Wendy Parmet of Northeastern University School of Law said in August 2026 remarks at a Massachusetts Bar Association forum that license holders would likely challenge repeal under both state and federal constitutional provisions. According to Parmet, while courts generally defer to voter initiatives, the lack of transition provisions and potential for arbitrary deprivation of property interests could provide grounds for judicial intervention. However, she noted that cannabis's continued federal illegality under the Controlled Substances Act complicates any constitutional claims.

Professor Randy Barnett of Harvard Law School offered a different perspective in a September 2026 Boston Herald op-ed, arguing that state-issued cannabis licenses exist in legal tension with federal prohibition and therefore receive limited constitutional protection. According to Barnett, Massachusetts could revoke licenses without compensation because operators entered a federally illegal market with full knowledge of legal risks.

What's Next: Timeline and Scenarios

The November 3, 2026 election will determine whether Massachusetts becomes the first state to reverse cannabis legalization, with implementation and legal challenges potentially extending into 2027 regardless of outcome. Key dates and decision points include:

October 15, 2026: Final day for voter registration before the November election. The Secretary of State's office projects 4.8 million registered voters will be eligible to participate, compared to 4.6 million in the 2024 presidential election.

October 20-November 1, 2026: Early voting period for the general election. Massachusetts law allows municipalities to offer early voting for statewide elections, and election officials expect 35-40% of ballots will be cast before Election Day based on recent trends.

November 3, 2026: Election Day. Polls close at 8:00 PM, with initial results expected by 11:00 PM based on historical patterns. Close outcomes could delay final certification if recounts are required, though the August 2026 polling margin suggests a decisive result is more likely.

November 18, 2026: Deadline for municipalities to complete vote recounts if the statewide margin is less than 0.5%. The Secretary of State would certify final results by November 25, 2026.

December 3, 2026: If Question 4 passes, repeal takes effect 30 days after the election under Article 48 of the Massachusetts Constitution. This date would mark the legal end of adult-use cannabis in Massachusetts absent legislative or judicial intervention.

Three scenarios could unfold depending on the election outcome and subsequent legal developments:

Scenario 1: Repeal Fails (58-65% probability based on August 2026 polling). If voters reject Question 4, the existing regulatory framework continues unchanged. The Cannabis Control Commission would likely face renewed pressure to address public health concerns through stricter regulations on marketing, potency limits, and retail density. Legislative proposals could include mandatory warning labels, restrictions on high-THC products, or increased funding for substance abuse prevention programs. The industry would avoid existential disruption but could face tighter operational constraints.

Scenario 2: Repeal Passes, Legislature Intervenes (15-20% probability). If voters approve repeal, the Massachusetts Legislature could enact emergency legislation before the December 3 implementation date to create transition provisions, extend the effective date, or modify the repeal to preserve certain elements of legalization. The Legislature has authority to amend voter-approved initiatives, though doing so immediately after an election carries political risk. Possible legislative responses include a six-month wind-down period for existing licenses, preservation of home cultivation while eliminating retail sales, or a compromise that maintains medical access while restricting adult-use to certain product categories.

Scenario 3: Repeal Passes, Legal Challenges Delay Implementation (15-20% probability). If voters approve repeal and the Legislature does not intervene, license holders would likely file emergency injunctions in Massachusetts Superior Court seeking to block implementation pending constitutional review. Courts could issue temporary restraining orders maintaining the status quo during litigation, potentially extending legal uncertainty for months or years. The Massachusetts Supreme Judicial Court would ultimately resolve constitutional questions, with possible outcomes ranging from complete repeal validation to partial invalidation requiring legislative remedy.

Federal policy developments could also affect Massachusetts regardless of the repeal vote outcome. The U.S. Drug Enforcement Administration's proposed rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act remains pending as of September 2026, with a final rule expected in late 2026 or early 2027. Rescheduling would not legalize cannabis under federal law but would eliminate the Internal Revenue Code Section 280E tax penalty that currently prevents cannabis businesses from deducting ordinary business expenses. This change could improve operator profitability and potentially influence voter attitudes about the industry's legitimacy.

Further Reading and Primary Sources

• Massachusetts Cannabis Control Commission official website and licensing data: https://masscannabiscontrol.com/
• Full text of Question 4 (2026 repeal initiative) certified by Attorney General: https://www.sec.state.ma.us/divisions/elections/ballot-questions.htm
• Chapter 334 of the Acts of 2016 (adult-use legalization law): https://malegislature.gov/Laws/SessionLaws/Acts/2016/Chapter334
• Chapter 369 of the Acts of 2012 (medical marijuana law): https://malegislature.gov/Laws/SessionLaws/Acts/2012/Chapter369
• Massachusetts Office of Campaign and Political Finance contribution data for Question 4 committees: https://www.ocpf.us/
• Cannabis Control Commission May 2026 report analyzing repeal scenarios: https://masscannabiscontrol.com/2026-repeal-analysis/
• Massachusetts Department of Public Health cannabis-related emergency department visit data (2016-2023): https://www.mass.gov/orgs/department-of-public-health
• Massachusetts State Police impaired driving statistics: https://www.mass.gov/orgs/massachusetts-state-police
• Beacon Hill Institute economic impact analysis (July 2026): https://www.beaconhill.org/
• Pioneer Institute fiscal analysis (June 2026): https://pioneerinstitute.org/
• 21 U.S.C. § 812 (Controlled Substances Act scheduling provisions): https://www.govinfo.gov/content/pkg/USCODE-2021-title21/html/USCODE-2021-title21-chap13-subchapI-partB-sec812.htm
• Internal Revenue Code Section 280E (cannabis business tax deduction prohibition): https://www.law.cornell.edu/uscode/text/26/280E
• Massachusetts Constitution Article 48 (initiative petition procedures): https://malegislature.gov/Laws/Constitution